In conclusion, our research showed that FAIM2 was significantly upregulated in NSCLC tissues and performed an oncogenic function in tumor progression, including tumor cell proliferation and bone metastasis. This evidence concerns the gene FAIM2 and non-small cell lung carcinoma.